Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia
Clinical trial NCT05215015 · UNKNOWN
Trial details
- NCT number
- NCT05215015
- Sponsor
- Wuxi People's Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2022-11-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.